ICAD（頭蓋内アテローム性動脈硬化症）病理治療の世界市場2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D0GIR-02701 • 出版社/出版日：GlobalInfoResearch / 2020年9月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、ICAD（頭蓋内アテローム性動脈硬化症）病理治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。ICAD（頭蓋内アテローム性動脈硬化症）病理治療の種類別市場規模（ステント、PTAバルーン）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Stryker、MicroPort、Balt、TERUMO、Acandis ・地域別グローバル市場分析 2015年-2020年 ・ICAD（頭蓋内アテローム性動脈硬化症）病理治療の北米市場（アメリカ、カナダ、メキシコ） ・ICAD（頭蓋内アテローム性動脈硬化症）病理治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ICAD（頭蓋内アテローム性動脈硬化症）病理治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ICAD（頭蓋内アテローム性動脈硬化症）病理治療の南米市場（ブラジル、アルゼンチン） ・ICAD（頭蓋内アテローム性動脈硬化症）病理治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ステント、PTAバルーン ・用途別分析：病院、クリニック、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論

Market Overview
The ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The most likely (base case) scenario is that the global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment sales will be xx in 2020 from ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment market size is expected to grow at xx% or more annually for the next five years.

This report also researches and evaluates the impact of Covid-19 outbreak on the ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).

Market segmentation
ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment market has been segmented into:
Stent
PTA Balloon

By Application, ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment has been segmented into:
Hospital
Clinic
Other

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment market.

The report offers in-depth assessment of the growth and other aspects of the ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share Analysis
ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment sales, revenue and market share for each player covered in this report.

The major players covered in ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment are:
Stryker
MicroPort
Balt
TERUMO
Acandis
Among other players domestic and global, ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

レポート目次

---

1 ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Overview
1.1 Product Overview and Scope of ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment
1.2 Classification of ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment by Type
1.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Market Share by Type in 2019
1.2.3 Stent
1.2.4 PTA Balloon
1.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market by Application
1.3.1 Overview: Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market by Regions
1.4.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Industry Impact
1.5.1 COVID-19 Potential Implications for the ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Stryker
2.1.1 Stryker Details
2.1.2 Stryker Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Stryker SWOT Analysis
2.1.4 Stryker Product and Services
2.1.5 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 MicroPort
2.2.1 MicroPort Details
2.2.2 MicroPort Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 MicroPort SWOT Analysis
2.2.4 MicroPort Product and Services
2.2.5 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Balt
2.3.1 Balt Details
2.3.2 Balt Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Balt SWOT Analysis
2.3.4 Balt Product and Services
2.3.5 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 TERUMO
2.4.1 TERUMO Details
2.4.2 TERUMO Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 TERUMO SWOT Analysis
2.4.4 TERUMO Product and Services
2.4.5 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Acandis
2.5.1 Acandis Details
2.5.2 Acandis Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Acandis SWOT Analysis
2.5.4 Acandis Product and Services
2.5.5 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Players Market Share
3.2.2 Top 10 ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Market Share by Regions
4.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Growth Rate (2015-2020)
4.5 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Growth Rate (2015-2020)
5 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue by Countries
5.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue by Countries (2015-2020)
5.2 USA ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Growth Rate (2015-2020)
6 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue by Countries
6.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue by Countries (2015-2020)
6.2 Germany ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Growth Rate (2015-2020)
6.3 UK ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Growth Rate (2015-2020)
6.4 France ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue by Countries
7.1 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue by Countries (2015-2020)
7.2 China ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Growth Rate (2015-2020)
7.5 India ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Growth Rate (2015-2020)
8 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue by Countries
8.1 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue by Countries (2015-2020)
8.2 Brazil ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment by Countries
9.1 Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Forecast by Type (2019-2024)
10.3 Stent Revenue Growth Rate (2015-2025)
10.4 PTA Balloon Revenue Growth Rate (2015-2025)
11 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Segment by Application
11.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Market Share by Application (2015-2020)
11.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Clinic Revenue Growth (2015-2020)
11.5 Other Revenue Growth (2015-2020)
12 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size Forecast (2021-2025)
12.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size Forecast (2021-2025)
12.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Forecast by Regions (2021-2025)
12.3 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Market Forecast (2021-2025)
12.4 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Market Forecast (2021-2025)
12.6 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Stryker Corporate Information, Location and Competitors
Table 7. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Major Business
Table 8. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Total Revenue (USD Million) (2017-2018)
Table 9. Stryker SWOT Analysis
Table 10. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Product and Solutions
Table 11. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. MicroPort Corporate Information, Location and Competitors
Table 13. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Major Business
Table 14. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Total Revenue (USD Million) (2018-2019)
Table 15. MicroPort SWOT Analysis
Table 16. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Product and Solutions
Table 17. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Balt Corporate Information, Location and Competitors
Table 19. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Major Business
Table 20. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Total Revenue (USD Million) (2017-2018)
Table 21. Balt SWOT Analysis
Table 22. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Product and Solutions
Table 23. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. TERUMO Corporate Information, Location and Competitors
Table 25. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Major Business
Table 26. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Total Revenue (USD Million) (2017-2018)
Table 27. TERUMO SWOT Analysis
Table 28. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Product and Solutions
Table 29. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Acandis Corporate Information, Location and Competitors
Table 31. Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Major Business
Table 32. Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Total Revenue (USD Million) (2017-2018)
Table 33. Acandis SWOT Analysis
Table 34. Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Product and Solutions
Table 35. Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue (Million USD) by Players (2015-2020)
Table 37. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Share by Players (2015-2020)
Table 38. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue (Million USD) by Regions (2015-2020)
Table 39. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Market Share by Regions (2015-2020)
Table 40. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue by Countries (2015-2020)
Table 41. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Market Share by Countries (2015-2020)
Table 42. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue (Million USD) by Countries (2015-2020)
Table 43. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue (Million USD) by Countries (2015-2020)
Table 44. South America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue by Countries (2015-2020)
Table 45. South America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Market Share by Countries (2015-2020)
Table 46. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue (Million USD) by Countries (2015-2020)
Table 47. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Market Share by Countries (2015-2020)
Table 48. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue (Million USD) by Type (2015-2020)
Table 49. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Share by Type (2015-2020)
Table 50. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Forecast by Type (2021-2025)
Table 51. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue by Application (2015-2020)
Table 52. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Share by Application (2015-2020)
Table 53. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Forecast by Application (2021-2025)
Table 54. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Picture
Figure 2. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Market Share by Type in 2019
Figure 3. Stent Picture
Figure 4. PTA Balloon Picture
Figure 5. ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Market Share by Application in 2019
Figure 6. Hospital Picture
Figure 7. Clinic Picture
Figure 8. Other Picture
Figure 9. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Share by Players in 2019
Figure 17. Global Top 5 Players ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Market Share in 2019
Figure 18. Global Top 10 Players ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Market Share by Regions (2015-2020)
Figure 22. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Market Share by Regions in 2018
Figure 23. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Growth Rate (2015-2020)
Figure 24. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Growth Rate (2015-2020)
Figure 26. South America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Growth Rate (2015-2020)
Figure 28. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Market Share by Countries (2015-2020)
Figure 29. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Market Share by Countries in 2019
Figure 30. USA ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Growth Rate (2015-2020)
Figure 31. Canada ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Growth Rate (2015-2020)
Figure 32. Mexico ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Growth Rate (2015-2020)
Figure 33. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Market Share by Countries (2015-2020)
Figure 34. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Market Share by Countries in 2019
Figure 35. Germany ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Growth Rate (2015-2020)
Figure 36. UK ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Growth Rate (2015-2020)
Figure 37. France ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Growth Rate (2015-2020)
Figure 38. Russia ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Growth Rate (2015-2020)
Figure 39. Italy ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Market Share by Countries in 2019
Figure 42. China ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Growth Rate (2015-2020)
Figure 43. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Growth Rate (2015-2020)
Figure 44. Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Growth Rate (2015-2020)
Figure 45. India ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Growth Rate (2015-2020)
Figure 47. South America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Market Share by Countries (2015-2020)
Figure 48. South America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Market Share by Countries in 2019
Figure 49. Brazil ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Growth Rate (2015-2020)
Figure 50. Argentina ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Growth Rate (2015-2020)
Figure 54. UAE ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Growth Rate (2015-2020)
Figure 55. Egypt ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Growth Rate (2015-2020)
Figure 56. South Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue and Growth Rate (2015-2020)
Figure 57. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Share by Type (2015-2020)
Figure 58. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Share by Type in 2019
Figure 59. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share Forecast by Type (2021-2025)
Figure 60. Global Stent Revenue Growth Rate (2015-2020)
Figure 61. Global PTA Balloon Revenue Growth Rate (2015-2020)
Figure 62. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Share by Application (2015-2020)
Figure 63. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Share by Application in 2019
Figure 64. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market Share Forecast by Application (2021-2025)
Figure 65. Global Hospital Revenue Growth Rate (2015-2020)
Figure 66. Global Clinic Revenue Growth Rate (2015-2020)
Figure 67. Global Other Revenue Growth Rate (2015-2020)
Figure 68. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Market Forecast (2021-2025)
Figure 72. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Market Forecast (2021-2025)
Figure 74. South America ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel

---